𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon-based Therapy for e-antigen Negative Chronic Hepatitis B Virus Infection

✍ Scribed by Fayaz A. Handoo, Hamdan AlGhamdi, Faisal M. Sanai, Ibrahim H. Altraif

Book ID
118819592
Publisher
Current Science Inc.
Year
2012
Tongue
English
Weight
176 KB
Volume
11
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum hepatitis B virus-DNA cutoff level
Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen–negative chronic hepatitis B virus infection
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Athanasio πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 52 KB πŸ‘ 2 views

Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255-260. 6. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-438. 7. Magnes

Hepatitis B virus DNA prediction rules f
Hepatitis B virus DNA prediction rules for hepatitis B e antigen–negative chronic hepatitis B
✍ Jordan J. Feld; Melissa Ayers; Dahlia El-Ashry; Tony Mazzulli; Raymond Tellier; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 672 KB

After hepatitis B e antigen (HBeAg) seroconversion, hepatitis B may become inactive or progress to HBeAg-negative hepatitis with persistent or intermittent alanine aminotransferase (ALT) elevation. The aim of this study was to prospectively identify factors predictive of the clinical course in HBeAg